All In Biotech

Drug Trial Radar · NCT07288398

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

540

Planned (sponsor's estimate)

Start

Mar 3, 2026

Primary completion

Jun 30, 2028

Study completion Jun 30, 2029

Sponsor

Lead sponsor
Tenax Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Dec 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance.

Conditions

  • Pulmonary Hypertension Associated With HFpEF

Interventions

  • TNX-103Drug

    Oral levosimendan

  • PlaceboDrug

    Matching placebo (oral)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-Minute Walk Distance (6MWD)Time frame: 26 weeks

Locations

140 sites in 15 countries. Site status is shown where the registry gives one.

  • Tenax Investigational Site

    Alexander City, Alabama

  • Tenax Investigational Site

    Tucson, Arizona

  • Tenax Investigational Site

    Sacramento, California

  • Tenax Investigational Site

    San Francisco, California

  • Tenax Investigational Site

    Stanford, California

  • Tenax Investigational Site

    Torrance, California

  • Tenax Investigational Site

    Athens, Georgia

  • Tenax Investigational Site

    Atlanta, Georgia

  • Tenax Investigational Site

    Chicago, Illinois

  • Tenax Investigational Site

    Chicago, Illinois

  • Tenax Investigational Site

    Mount Prospect, Illinois

  • Tenax Investigational Site

    Peoria, Illinois

  • Tenax Investigational Site

    Indianapolis, Indiana

  • Tenax Investigational Site

    New Orleans, Louisiana

  • Tenax Investigational Site

    West Monroe, Louisiana

  • Tenax Investigational Site

    Boston, Massachusetts

  • Tenax Investigational Site

    Ann Arbor, Michigan

  • Tenax Investigational Site

    Ypsilanti, Michigan

  • Tenax Investigational Site

    Minneapolis, Minnesota

  • Tenax Investigational Site

    Rochester, Minnesota

  • Tenax Investigational Site

    Kansas City, Missouri

  • Tenax Investigational Site

    St Louis, Missouri

  • Tenax Investigational Site

    Omaha, Nebraska

  • Tenax Investigational Site

    Reno, Nevada

  • Tenax Investigational Site

    New York, New York

  • Tenax Investigational Site

    New York, New York

  • Tenax Investigational Site

    Rochester, New York

  • Tenax Investigational Site

    Durham, North Carolina

  • Tenax Investigational Site

    Winston-Salem, North Carolina

  • Tenax Investigational Site

    Cleveland, Ohio

  • Tenax Investigational Site

    Columbus, Ohio

  • Tenax Investigational Site

    Allentown, Pennsylvania

  • Tenax Investigational Site

    Pittsburgh, Pennsylvania

  • Tenax Investigational Site

    Wynnewood, Pennsylvania

  • Tenax Investigational Site

    Charleston, South Carolina

  • Tenax Investigational Site

    Nashville, Tennessee

  • Tenax Investigational Site

    Austin, Texas

  • Tenax Investigational Site

    Dallas, Texas

  • Tenax Investigational Site

    El Paso, Texas

  • Tenax Investigational Site

    Houston, Texas

Showing 40 of 140 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.